PharMerica and its subsidiary Amerita’s Specialty Infusion Services (Amerita) are already facing class action lawsuits after patients received a September 5, 2023, data breach notification letter. When the businesses detected suspicious activity on both the PharMerica and Amerita networks, a forensic investigation determined that a threat actor had gained access to the systems sometime in…